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‘Whoever controls the seed today could rule over nations tomorrow’. 
Mary C. Carras 
 
 This article discusses and evaluates the potential impact of the modern biotechnological revo-
lution (genetic engineering) on food security in developing countries. It finds that within the 
present framework, where innovations are driven by profit rather than by need-oriented re-
search and development, the biotechnological revolution can have an adverse effect on small 
farms and exacerbate social, economic and environmental problems. Given that the current 
debate on biotechnology entered a period of intensified conflict over questions of ownership 
and control over biological materials, the role of patenting and Intellectual Property Rights 
(IPRs) is specifically highlighted. In conclusion, much emphasis is given to the international at-
tempts at control of biotechnology within the UN system with particular regard to the Cartage-
na Protocol on Biosafety and the FAO International Treaty on Plant Genetic Resources for 
Food and Agriculture and their attempts to set guidelines governing trade in genetically modi-
fied organisms and to strengthen the concept of ‘farmer’s rights’. 
 
The new technologies associated with genetic engineering and commonly referred to as bio-
technology are increasingly perceived by their promoters and critics as so ground-breaking that 
their impact on farming, agriculture and food systems will far surpass that of the twentieth 
century industrial revolution. Consequently, many authors dealing with the issue of biotechnol-
ogy and development point to the lessons learned from the ‘Green Revolution’ when the 
western industrial model of agriculture was exported to the developing world, producing mixed 
results [1,2,14,15,18]. In this article, first these lessons are reviewed and the current genetic 
revolution in developing countries is outlined. Subsequently, food security is redefined and 
agro-industry myths are debunked. The article continues with a discussion of intellectual prop-
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erty rights applied to biotechnology. Finally, international environmental regimes that aim to 
defend biodiversity and farmer’s rights are reviewed. 
Lessons from the Green Revolution and the current pace of the genetic revolution in develop-
ing countries 
Though it is true that the Green Revolution was highly successful in initially increasing crop 
yields and aggregate food supplies, it has also been responsible for causing many environmen-
tal and socio-economic problems. By its promotion of the industrial farming model, favouring 
mostly export cash crops producing farms that have enough resources to purchase expensive 
chemical and mechanic inputs, the Green Revolution has failed to address the issue of food 
access and contributed to the erosion of genetic varieties in the food systems [1,2,10,18]. The 
technological change introduced by the Green Revolution has discriminated against small, 
sustenance-level production, contributing to the loss of food self-sufficiency and agro-biodi-
versity at the local level among many areas of Asia, Latin America and Africa [21]. In addition, 
the reliance on chemical fertilisers has not only led to a major environmental crisis by leading 
to new ‘ecological diseases’ [22] but has also made developing countries’ food production 
dependent on expensive imports of agro-chemicals and machinery [1]. Essentially, although the 
Green Revolution contributed to the overall global food security in an aggregate sense, it has 
failed to address specific food security needs at household, intra-household and community 
levels and failed to deliver its promise of ending world hunger with today more than 850 
million people being undernourished [23]. At the same time the Green Revolution is partially 
responsible for entrenching an unsustainable food production system favouring monocultures 
and exacerbating both environmental degradation and an unequal distribution of resources. 
It is within this context that ironically virtually the same few firms that have profited the 
most from agro-chemical sales to developing countries are today’s leaders of biotechnological 
research and development (R&D), marketing their new products as a solution to hunger that 
will turn farming into an environmentally friendly process with increased yields and profitabil-
ity. ‘According to FAO (Food and Agriculture Organisation of the United Nations), the five 
largest plant biotechnology companies are all large multinational corporations with important 
interests in agro-chemical sales: DuPont, ICI, Monsanto, Sandoz and Ciba-Geigy’ [12]. The 
majority of biotechnological R&D takes place within the rich OECD countries, ‘where most 
expenditures are directly accounted for by private-sector firms with much public-sector R&D 
undertaken for the indirect benefit of private firms’ [3]. Overall, 70 percent of agricultural 
biotechnology investments are by private sector research and only four firms – DuPont, 
Monsanto, Syngenta and Bayer – control nearly 100 percent of the market in genetically 
modified (GM) products for agriculture. Only a handful of advanced developing countries have 
their own biotechnological programmes, among them being Argentina, India, Mexico, Brazil 
and China. By 2001, over 75% of GM crops have been planted in industrialised countries and 
substantial planting concerns only four crops – soybean, maize, cotton and canola – while 
there are no serious investments in most important crops for the semi-arid tropics. Addition-
ally, given that increasing market share and control has become the guiding principle of the 
present-day biotechnological revolution in agriculture, the two greatest advances and most 
common traits of genetic modification are insect resistance and herbicide tolerance [9,12]. 
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Concentration of research in biotechnology in the private domain, controlled by a few 
multinational companies of the North, and coupled with development of an international pa-
tenting regime, are the most crucial factors in shaping the socio-economic, environmental and 
the food-security consequences of biotechnological innovations for the developing countries. 
Biotechnology via ‘genetic engineering’ involves ‘the excision of individual genes or sec-
tions of chromosomes from a particular genome and their transfer into a different cell and, 
thus, a different genomic background’ [13]. This extraction and replacement of genes allows 
for overcoming the species’ biological and chemical barriers as well as for rapid movement of 
genetic material to create new micro-organisms, plants, and animals. Given that genetic materi-
al can now be exchanged among all living organisms within a short time combined with the 
new developments in patenting rights has put biotechnological R&D largely outside of the 
public domain’s regulations. ‘Companies are striving to develop novel biotechnology products 
as quickly as possible, while simultaneously lobbying to reduce as much as possible the public 
regulatory processes’ [15]. In fact, companies are massively deploying genetically engineered 
plants around the world, usually without proper short and long term testing of their impact on 
health and environment. The rate of growth in the cultivation of genetically modified organ-
isms (GMOs) during the past 5 years has been truly striking: in 2003 over 67 million hectares 
were cultivated with GMO crops as compared with only 11 million hectares in 1998 [24]. This 
rapid release of GMOs into environment has brought with it the consequences of genetic conta-
mination of traditional varieties due to effects of cross-pollination, mixing with batches of GM 
seeds or illegal introduction of seeds without the explicit consent of a particular developing 
country. The location of transgenic maize crops in Mexican fields in 2001 [25], despite the 
Mexican moratorium on GMO crops established in 1998, is particularly disturbing as it serves to 
demonstrate the ease with which the GMO crops have contaminated other non-GMO varieties 
at the centres of origin of the crop’s biodiversity [26]. 
The FAO [48] lists two levels of potential risks posed by genetic engineering: its effects on 
human and animal health as well as its effects on the environment. Among the risks to human 
and animal health is the potentiality of transfer of toxins from one life form to another, 
including substances responsible for allergic reactions. Risks to the environment are many, 
including the loss of biodiversity in favour of fewer new GMO crops and associated problems 
related to upsetting balance of the ecosystem. Some examples are the risk of contamination of 
the world’s genetic resources and the risk of development of new more aggressive weeds with 
resistance to diseases and pesticides [27]. 
The present structure of the ‘gene revolution’ based on profit rather than need-motivated 
deployment of seed products coupled with enforcement of IPRs and absence of a fully imple-
mented regulatory and biosafety framework, could have a disastrous effect on the developing 
countries’ food security. This is why it is necessary to conduct research that addresses particu-
lar countries’ environmental and socio-economic circumstances as well as the needs of the 
smallholder farmers. Furthermore, independent risk assessment of GMOs needs to be strength-
ened and national and international guidelines must be developed and supported on biosafety 
and preservation of biodiversity. All this is necessary to assure that the new technologies will 
not have a negative effect on global food security. 
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Redefining food security and debunking agro-industry myths 
The concept of ‘food security’ has been undergoing many changes during the last 50 years and 
today it is widely acknowledged to mean much more than physical availability of food on the 
market in proportion to population. Although Malthusian anticipation over two centuries ago 
that food production would not keep up with population growth has never materialised in 
view of the fact that the world produces more food per inhabitant today then ever before, 
somehow the myth that hunger is rooted in the gap between food production and human 
population density and growth rate seems to persist in the mainstream view. The aftermath of 
the Green Revolution as well as ground-breaking studies of the roots of famines by Noble 
price winning economist Amartya Sen and others have moved the focus from aggregate 
production to the role of economic access and distribution. Sen has repeatedly shown that 
famines occur even without any decline in food production or availability (e.g., the Bangladesh 
famine of 1974 during the country’s peak level of food production) and FAO’s statistics 
demonstrate that on the global scale the food production rate, despite sometimes serious re-
gional variations, is going upwards and in tune with population growth [17]. 
FAO defines food security as existing when ‘all people at all times have access to safe 
nutritious food to maintain a healthy and active life’. There are three dimensions of food secu-
rity according to FAO: availability, access and utilisation [28]. Each of these components needs 
to be considered at the level of individuals, households, nations and international relations. 
Additionally, the UN Conference on Environment and Development (1992) and the World 
Conference on Women (1995) have highlighted the principle of social access to food of wom-
en (the feminisation of agriculture and poverty, distribution within households) and the role of 
environmental factors in food security. In particular, sustainability of agricultural practices and 
the role of other environmental aspects, such as clean drinking water, have come into the 
forefront in the assessment and accounting for today’s food security. 
It is within this context that M. S. Swaminathan has proposed a comprehensive definition 
of food security in preparation for the 1996 World Food Summit: 
 
Policies and technologies for sustainable food security should ensure: 
That every individual has the physical, economic, social and environmental access to a 
balanced diet that includes the necessary macro- and micro-nutrients, safe drinking 
water, sanitation, environmental hygiene, primary health care, and education so as to 
lead a healthy and productive life. 
That food originates from efficient and environmentally benign production technolo-
gies that conserve and enhance the natural resource base of crops, animal husbandry, 
forestry, inland and marine fisheries [19]. 
 
Swaminathan’s definition captures both the complexity and the multi-dimen sionality of food 
security with particular regard to environmental constraints and preservation of ecosystems. 
Keeping in mind that the majority of developing countries rely on smallholder farms and that 
hunger is caused by poverty, inequality and lack of access to food and to land, allows us to 
scrutinise the promises of agro-chemical industries. 
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Today, the main products of biotechnology revolve around patent-protected crops that 
are either herbicide resistant (e.g., Monsanto’s ‘Roundup Ready’ soybean seeds that are tolerant 
to Monsanto’s herbicide Roudup) or Bt (Bacillus thuringensis) crops engineered to produce their 
own insecticide. The logic behind herbicide resistance crops is the hope for the increased sales 
of herbicides from the same company. In the case of Bt crops, the expectation is to boost sales 
of patented crops while damaging the use of pest-management products used by most organic 
farmers instead of insecticides (the Bacillus thuringiensis is a bacterium that normally lives in the 
soil and produces toxins which kill the larvae of moths and almost nothing else). In fact, over 
one third of all biotechnological research on biological control agents focuses on transfer of 
the Bt gene into major crops [2,12]. According to entomologist Fred Gould, ‘if pesticidal 
plants are developed and used in a way that leads to rapid pest adaptation, the efficacy of these 
plants will be lost and agriculture will be pushed back to reliance on conventional pesticides 
with their inherent problems’ [12]. Since the expensive products of biotechnology require 
further input dependence from resource-poor farmers and lead to a probable damage to the 
environment, the result will be a higher risk to food security. 
Another use of biotechnology to the potential detriment of developing farmers’ interests 
is in industrial bio-processing and tissue culture. Present technology allows for the develop-
ment of industrial substitutes for plant-derived products, which can be produced in factories of 
developed countries. Such production of many typical Third World exports such as spices, fra-
grances and sweeteners is already well entrenched in the modern agro-industry. For example, 
the High Fructose Corn Syrope (HFCS) is presently being produced by converting corn into a 
sweetener and has already gained wide use in such products as soft drinks. When HFCS attained 
widespread use, the world demand for sugar went down, threatening the livelihoods of an 
estimated eight to ten million people in the South and a total collapse of entire economies in 
the Caribbean and of sugar-producing regions in the Philippines [15,12]. The trend for devel-
opment of sugar substitution products in the West is on the rise with aspartame being already 
consumed in large quantities. Among other modern R&D advances that have an adverse impact 
on major Third World products is cocoa and vanilla in-vitro production. The possibility that 
protein engineering techniques will be applied to conversion of low price oils (e.g., olive, sun-
flower and palm oil) into cocoa butter or utilising cell culture for the ‘biosynthesis’ of cocoa 
butter in a factory is also on the horizon [3]. According to Buttel [3], the impacts of such devel-
opments on developing countries will depend on the importance that a given raw material has 
as a source of export revenues. Therefore, for example countries such as Ghana and Came-
roon, who earn most of their foreign exchange from cocoa, will be most dramatically affected 
and risk high levels of poverty and unemployment in areas where the crop has been cultivated. 
Other major cocoa suppliers, such as Brazil and Malaysia, having more diversified exports and 
production systems dominated by large-scale plantations, will probably be less affected in com-
parison to small producers in Africa. Keeping in mind that promotion of single export crops 
for raising export revenues has been heavily promoted in Africa by multilateral financial orga-
nisations, the countries’ risk to food security due to bio-processing could be paramount. ‘Bio-
technology thus raises the possibility of a significant restructuring of the world food economy 
caused by the possible industrialisation of food production, and the relegation of agriculture to 
production of biotechnology feedstocks’ [3]. 
A major argument used by biotechnology industries is that transgenic crops will signifi-
cantly increase crop yields. Even putting aside the fact that increased yields alone might lead to 
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increased development of monocultures and do not address developing countries’ food secu-
rity dilemma, studies conducted by the US Department of Agriculture (USDA) Economic 
Research Service and University of Nebraska shed doubt on the increased yields hypothesis. 
USDA analysed data collected in 1997 and 1998 from different region/crop combinations of Bt 
corn and cotton, herbicide tolerant corn, cotton and soybeans, and their non-engineered coun-
terparts. No conclusive difference was found between GMO and non-GMO crops yield increases 
[29]. Additionally, the University of Nebraska Institute of Agriculture and Natural Resources 
grew five different Monsanto soybean varieties and their closest non-engineered relatives and 
found that, on average, the genetically engineered crops produced six percent less than their 
conventional relatives and eleven percent less then the highest yielding conventional crops [2]. 
Altieri in his comprehensive study of biotechnological industry products points out that, 
in terms of increased yields, land reforms produce best results: ‘While industry proponents will 
often forecast 15, 20 or even 30 percent yield gains from biotechnology, smaller farms today 
produce from 200-1,000 percent more per unit area than larger farms world wide’ [2]. 
When the multi-dimensional aspects of food security are acknowledged, it becomes clear 
that as long as biotechnological companies operate under the premise that hunger and poverty 
can be fixed by increased production and that the only way to do so is by genetic engineering 
of crops – without due regard for ecosystems, farmers control and access to crops and biodi-
versity –, the future food security of the developing world is most definitely not going to 
improve. 
The patently problematic biotechnology 
Perhaps the most voiced and contested aspect of biotechnology involves questions of patent-
ing and expansion of Intellectual Property Rights (IPRs) within the realm of international and 
national laws. From the perspective of developing countries, patents can be seen as both obsta-
cles to the transfer of available technologies – keeping poor farmers from affordably obtaining 
currently expensive seeds – as well as a new form of control over biological material and ‘tradi-
tional knowledge’. 
According to Fowler and Shiva, the developing countries’ criticism of patents has a long 
history and patents are often perceived as an extension of colonial control over Third World 
natural resources. From this perspective ‘patents may be seen by some as a civil right, but it 
would be more appropriate to view them as a legal mechanism of control in the marketplace’ 
[8]. 
The consolidation and industrialisation of the seed industry with the growing importance 
of plant-breeding methods gave rise to the modern patent system related to the creation of 
new life forms. The Union for Protection of New Varieties of Plants was established in 1961 in 
order to promote ‘plant breeders rights’ (PBRs). The PBRs still provided for ‘research’ and 
‘farmers’ exemptions, meaning that the farmers were allowed to save seeds for replanting. For 
developing country’s farmers consolidation of plant breeders rights meant that the reinter-
pretation of invention to include discovery had begun. Nevertheless, the direct patenting of life 
forms remained very problematic for long, with the European Patent Convention expressively 
prohibiting patenting of plant varieties and with conflicts of interest over international patent 
reform at the World Intellectual Property Organisation. Already back in the 1960s developing 
countries have been firm in voicing their opposition to patenting rights via the United Nations 
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Conference on Trade and Development. According to Fowler, such developing countries’ 
opposition to patents has led the United States to push for change of the arena for discussion 
of international enforcement of IPRs. It is not a coincidence that IPRs gained a new level of 
significance at the GATT (General Agreement on Tariffs and Trade), known today as the World 
Trade Organisation (WTO) [8,51]. 
Undoubtedly the advent of the biotechnological revolution has been one of the driving 
forces behind the US’s and other developed countries’ insistence on the importance of IPRs. 
The scope of coverage of patents given in the US and Europe have begun to include genes and 
variety characteristics by treating the new genetically modified product as an invention. The 
landmark event for patenting of plants has been the 1985 judgement in the United States in 
which molecular genetic scientist Kenneth Hibberd was granted patents on the tissue culture 
and the seed and whole plant of maize line selected from the tissue culture. This application 
included 260 separate claims giving him the right to exclude others from the use of any of the 
260 aspects [18]. For the developing country farmer it meant that she could no longer save and 
replant such a protected seed without violating a law. In fact one of the greatest controversies 
surrounding the present day patents protecting genetically modified seeds deals with the 
prerequisite that a farmer purchases the GMO seed from a company each year without resorting 
to the age-old tradition of saving seeds for the next year’s cultivation. 
Another major conflict in the IPR domain is the patenting of products and processes 
derived from plants on the basis of indigenous knowledge. There are many examples of plant 
and micro-organism varieties that have been granted a patent in the West in ignorance of the 
fact that the patented subject has been used for centuries in some ethnic community. The 
examples range from the patent applications on the traditional African plant Eddod to kill 
Zebra mussels [30] to the biopesticidal properties of the Indian plant Neem known as 
Azarichdita Indica [31]. In both cases knowledge of the properties of these plants existed and 
was applied in the respective communities since centuries. Although the patent system is often 
defended by its promoters as a human right that rewards creativity of an inventor, in the cases 
mentioned above the real inventors, that is the developing countries’ farmers, are not expected 
to see any benefits while at the same time the concept of common heritage on which 
development of indigenous knowledge depends is being eroded. Although the value of the 
patent is dependent on its source from nature’s diversity, it is what Shiva defines as ‘tinkering’ 
that becomes the source of creation. ‘The issue of IPRs is closely related to the issue of value. If 
all value is seen as being associated with capital, tinkering becomes necessary to add value. 
Simultaneously, value is taken away from the source (biological resources as well as indigenous 
knowledge), which is reduced to raw material’ [18]. In effect, the rich resources of indigenous 
knowledge due to their communal ownership, uncertain date of creation and unwritten form 
do not fit the requirements of the western system of IPRs. This helps to explain why although a 
vast majority of Western patents issued on derived properties originates from the developing 
countries’ biodiversity, less than 5 percent of the patents granted in developing countries are 
used there in production processes while fewer than 1 percent of the patents issued in 
developing countries go to developing countries’ nationals. Additionally, inventors in poor 
countries would find it hard to patent their discoveries in the West given the high costs 
associated with securing a patent (at least $ 4,000 in the US) [32] not to mention the legal costs 
associated with defending it. An insight to the functioning of IPRs in the American system is 
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illustrated by the fact that Genetech, a major US biotech company, has four times as many 
lawsuits to protect its patents as it has products [8]. 
Since the 1990s the push towards internationally recognised patents has gained momen-
tum under the World Trade Organisation’s TRIPS (Trade Related Aspects of Intellectual Pro-
perty Rights) [50], which set standards for the legal protection of intellectual property. The 
world’s poorest countries were given until 2006 to comply in full with the requirements of the 
TRIPS treaty [33]. The TRIPS lay the ground rules describing the IPR protections that each 
member country must provide, or to put it in other words, the absence of intellectual property 
rights protection constitutes an unfair trade barrier under WTO. Although the TRIPS Article 27.3 
excludes from patentability ‘plants and animals other than micro-organisms, and essentially 
biological processes for the production of plants or animal other than non-biological and 
microbiological processes’ (emphasis added), this wording creates specific constraints for 
developing countries’ own research and development in the area of bio-engineering, given the 
patent walls constructed around these ‘non-biological’ processes [34]. Moreover, the patent 
protections of biotech companies put public independent research on risk assessment of their 
products at the mercy of the corporate willingness to release their seeds for testing [4]. 
So how can the IPR system work to benefit the world’s poor countries? The United 
Kingdom’s Department for International Development (DFID) has set up a Commission on 
Intellectual Property Rights which has produced a report published in September 2002 
affirming that developing countries should take their time to committing themselves to the 
Western system of IPR protection unless such systems are beneficial to their needs and that the 
West should not push for stronger requirements than those already contained in the TRIPS. The 
Commission in its Report entitled ‘Integrating Intellectual Property Rights and Development 
Policy’ recognises that IPRs have done little to recognise the services of farmers in selection, 
development and conservation of their traditional varieties on the basis of which modern 
breeding techniques have been built. The Report distinguishes between the needs of poor 
developing countries and of those with a solid base for conducting their own R&D in 
agricultural biotechnology. Consequently the Commission recommends that: 
 
Developing countries should generally not provide patent protection for plants and 
animals, as is allowed under Article 27.3(b) of TRIPS, because of the restrictions pat-
ents may place on use of seed by farmers and researchers. Rather they should consid-
er different forms of sui generis systems for plant varieties. 
Those developing countries with limited technological capacity should restrict the 
application of patenting in agricultural biotechnology consistent with TRIPS, and they 
should adopt a restrictive definition of the term ‘micro-organ-ism’. [35] 
 
Furthermore, the Commission recommends that the TRIPS that are undergoing review of 
its provisions in the TRIPS Council should preserve the right of countries not to grant patents 
for plants and animals, including genes and genetically modified plants and animals. More so, it 
lists the ways in which developing countries can meet TRIPS obligations by adopting alternative 
modes of protections such as Plant Variety Protections (UPOV) style legislation based on the 
1978 or 1991 Convention (although they may now only join the 1991 Convention), another 
form of sui generis system including landraces or patents on plant varieties. In terms of the 
Low Income Developing Countries, the Report advocates that they should be granted an 
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extended transition period for implementation of TRIPS until at least 2016. In addition, the 
Commission wishes to see more funding for public directed research in agricultural R&D and 
for preservation of the world’s ‘gene banks’. 
Most importantly, the Report strongly encourages all countries to ratify multilateral trea-
ties strengthening the concept of ‘farmer’s rights’, aiming at the protection of biodiversity and 
enforcement of biosafety such as the FAO’s International Treaty on Plant Genetic Resources 
for Food and Agriculture [49] and the Cartagena Protocol on Biosafety [46]. 
International environmental regimes in defence of biodiversity and farmer’s rights 
Both the developing and the developed world are seeking viable solutions to preserve the deli-
cate balance between gaining maximal societal rewards from newly available technologies while 
at the same time assuring preservation of the world’s rich resources, including biodiversity and 
indigenous knowledge. Humanity’s food security depends on the judicious utilisation of the 
latter resources. As with all technologies, biotechnology offers both great promises and many 
risks. Minimising those risks requires international co-operation and strengthening of the 
multilateral initiatives in environmental regulatory regimes. The UN Conference on Environ-
ment and Development held in Rio de Janeiro [36] has led to adoption of the Convention on 
Biological Diversity [47] which in turn led to the breakthrough in the work of FAO addressing 
issues of protection of biodiversity and farmer’s rights as well as to the adoption of the 
Cartagena Protocol on Biosafety in 2000. 
The International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA) 
The foundation for international action to ensure conservation, use and availability of plant 
genetic resources was the FAO Undertaking on Plant Genetic Resources agreed in 1983. In 
1989 the Undertaking has incorporated Farmers’ Rights ‘arising from the past, present and 
future contributions of farmers in conserving, improving, and making available plant genetic 
resources, particularly those in the centers of origin/diversity’ [37]. 
The breakthrough came with the adoption of the Convention on Biological Diversity of 
1992 which has allowed to transform the Undertaking into the International Treaty on Plant 
Genetic Resources for Food and Agriculture (ITPGRFA) that came into force on 29 June 2004 
[38]. The Treaty has the specific objective of facilitating access to plant genetic resources held 
by contracting parties, and those in international collections, for the common good, recognis-
ing that these are an indispensable raw material for crop genetic improvement and that many 
countries depend on genetic resources which have originated elsewhere. The ITPGRFA also 
recognises the contribution of farmers in conserving, improving and making available these 
resources, and that this contribution is the basis of Farmers’ Rights. It does not limit in any 
form the rights that farmers may enjoy under national law to save, use, exchange and sell farm-
saved seed. Nevertheless, the Treaty’s provisions leave it entirely up to national governments 
to implement Farmer’s Rights which on one hand gives countries autonomy in developing 
such legal protections while on the other does not protect countries that do not devise their 
own national mechanisms [39]. 
The rationale for Farmers’ Rights combines arguments about equity and economics. Plant 
breeders and the world at large benefit from conservation and development of plant genetic 
resources undertaken by farmers, but farmers are not recompensed for the economic value 
  54 ISYP Journal on Science and World Affairs, Vol. 1, No. 1, 2005  
 
 
 
they have contributed. The Commission on Intellectual Property states that ‘Farmers’ Rights 
may be seen as a means of providing incentives for farmers to continue to provide services of 
conservation and maintenance of biodiversity’ [40]. Moreover, by adopting the ITPGRFA, coun-
tries have a guarantee that possible extension of intellectual property protection does not carry 
risks of restricting farmers’ rights to reuse, exchange and sell seed, the very practices which 
form the basis of their traditional role in conservation and development of plant genetic re-
sources. 
Provisions of ITPGRFA have also developed a ‘Multilateral System’ through which signato-
ries agree to provide access to plant genetic resources from an agreed on list of crops that are 
deemed as important to food security. Signatories are also to encourage other institutions to 
become part of the ‘Multilateral System’ such as Consultative Group on International Agricul-
tural Research (CGIAR) and other national and private collections of genetic material. 
The Treaty has established an important principle by which any user of germoplasm mate-
rial should sign a standard Material Transfer Agreement (MTA) [41], which will incorporate the 
conditions for access agreed in the Treaty (paragraph 12.3) and provide for benefit sharing of 
proceeds from any commercialisation arising from the material through a Fund established 
under the Treaty. 
Notably, the Treaty provides for the establishment of a financing mechanism, funded by 
contributions and a share of the proceeds from commercialisation of regulated seeds. It is 
hoped that the financing mechanism will enable implementation of agreed plans for farmers 
‘who conserve and sustainably utilise plant genetic resources for food and agriculture’ [42] and 
lead to innovative methods of managing traditional knowledge of plant genetic resources. 
Inclusion of such a funding mechanism has proved to be the single most important ingredient 
in assuring the success and compliance in the past environmental agreements such as the 
Montreal Protocol on Substances that Deplete the Ozone Layer [16]. 
Ironically, due to the fast-track ratification of the Treaty its entry into force in June 2004 
has taken place before many of its aspects have been defined, including financial regulations 
and application criteria of the Multilateral Transfer Agreement. The Commission for Genetic 
Resources for Food and Agriculture (CGRFA) continued to act as the Interim Committee for 
the Treaty’s implementation during the CGRFA’s last meeting in November 2004 which has laid 
the groundwork for the first meeting of its Governing Body scheduled for 2006 [43]. Yet, the 
second meeting of the Commission acting as Interim Committee of the Treaty has postponed 
discussions on the definition of relations between the Treaty, NGOs and Inter-Governmental 
Organisations with respect to the Treaty’s financing mechanisms. The November 2004 meet-
ing, however, has been successful in developing the terms of reference for the creation of a 
group of experts who will work on the terms of the standard Multilateral Transfer Agreement 
(MTA) and in providing for a meeting of legal experts assigned the task of evaluating the 
procedures and operating mechanisms of the Governing Body. Currently, the provision of the 
necessary financial resources for the management and administrative tools is still not sufficient-
ly addressed in order to make the Treaty a vital mechanism for the governance of plant genetic 
material and its uses [44]. 
The investment of western countries in ITPGRFA is consistent with their goal of assuring 
that biotechnology tools will not threaten conservation of biodiversity while creating an incen-
tive for developing countries to support actions aimed at protecting biodiversity and indige-
nous knowledge. 
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The Cartagena Protocol on Biosafety 
According to the provisions of the Convention on Biological Diversity (Article 19.1), the work 
on a separate protocol on biosafety has begun through the establishment of the Working 
Group on Biosafety which met between 1996 and 1999 with the aim to finalise the text of the 
Cartagena Protocol on Biosafety at the meeting in Cartagena, Colombia in February 1999. 
Nevertheless, due to the widespread differences on the contentious issues of trade in genetical-
ly modified organisms such as the definition of LMOs (Living Modified Organisms) and the 
scope of the LMOs covered by the Protocol, the final document was adopted at the subsequent 
meeting in Montreal in January 2000 [11]. 
The goal of the protocol is to protect biological diversity from potential risks posed by 
introduction of LMOs, which is the Protocol’s way of deferring to GMOs, resulting from mod-
ern biotechnology. The backbone of the Protocol consists of the so-called Advanced Informed 
Agreement procedure for ensuring that countries are agreeing to the import of such organisms 
into their territory. The party of export is obliged to notify in writing the party of import of any 
given type of LMO covered by the Protocol. Then the importing party has 90 days to acknowl-
edge receipt of the notification and to either proceed with the Protocol’s decision procedure 
[45], or according to its domestic regulatory framework. The Protocol also establishes an Inter-
net-based Biosafety Clearing House, to which all decisions must be relayed. There are, 
however, five types of LMOs that due to the compromise between negotiating parties were kept 
outside of the Advanced Informed Agreement Procedure. These include most pharmaceuti-
cals, LMOs in transit to a third Party, LMOs destined for contained use, LMO-FFPs (intended for 
direct use as food or feed or for processing) and LMOs declared as safe by the Parties of the 
Protocol. In essence, it means that only LMOs destined for direct introduction to environment 
such as seeds and micro-organisms are covered by the Advanced Informed Agreement [46]. 
Still, other LMOs such as LMO-FFPs are subject to a less restrictive procedure (Article 11) in 
which parties making domestic decisions about the use of LMOs must still notify the Biosafety 
Clearing House and the importing party is responsible to develop and announce its own regu-
lations with respect to LMOs. This means that the burden of proof and the development of the 
regulatory system in relation to LMOs not covered by the Advanced Informed Agreement lies 
with the importing party. The Protocol also requires that shipments of commodities that con-
tain or may contain LMO-FFPs must be identified in their accompanying documentation, hence 
allowing countries to enforce their own labelling schemes for genetically modified products. 
According to Gupta, stating the exclusion for non Advanced Informed Agreement covered 
LMOs leaves open the possibility that in the future provisions of liability can also be applied to 
cover all LMOs [11]. 
Of the most breakthrough importance in international environmental law is that the Car-
tagena Protocol contains a strong reference to the precautionary principle. The precautionary 
principle holds that when a new technology may cause suspected harm, scientific uncertainty 
should not be used as the basis to prevent precautionary action [47]. The final text of the Pro-
tocol not only retains the reference to the principle in its objectives but also gives the right to 
the parties to take import-restrictive actions in operating articles dealing with the decision-
making on commodities and LMOs for planting. The Article 1 states that the objective of the 
Protocol is to be pursued ‘in accordance with the precautionary approach contained in Princi-
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ple 15 of the Rio Declaration on Environment and Development’. The Article 10 then states 
that ‘lack of scientific certainty…shall not prevent a party from taking a decision, as appropri-
ate, with regard to the import of the living modified organism in question (…)’ [48]. 
Given the strong incorporation of the precautionary principle into the text, the relation-
ship of the Protocol to the WTO remains a highly contested issue. Although the text states that 
‘this Protocol shall not be interpreted as implying a change in the rights and obligations of a 
Party under any existing international agreement’ another paragraph states that ‘the above reci-
tal is not intended to subordinate this Protocol to other international agreements’ [49]. The 
analysis of the International Institute on Sustainable Development suggests that the wording 
means that in case of a conflict both the Protocol and the WTO rules will have to be read as 
mutually supportive or, in other words, will be interpreted to suit different needs of the parties. 
At the moment the Protocol still lacks a dispute settlement mechanism and the issue of liability 
has been postponed giving the parties of the protocol 5 years for the completion of the draft-
ing of the rules and procedures on this matter. Yet, the Cartagena Protocol has been a great 
success so far in allowing for a compromise between different interests of negotiating parties 
and the fact that liability issues have been given more time to be addressed only strengthens its 
possibility of becoming a viable Treaty by allowing time and flexibility to address this issue, 
especially taking into consideration that it took as much as 10 years to draft an agreement on 
liability in the highly successful Basel Convention [11]. 
Many policy analysts hailed the Cartagena Protocol to be the best example so far of a 
workable structure in the body of international law that allows for reconciliation of trade and 
environmental objectives. It is also very specific in addressing both developed and developing 
countries’ concerns relating to the introduction of GMOs, hence ensuring that food security of 
all, specifically in terms of the environmental and health risks, can be sufficiently protected. 
Conclusions 
Although this article’s assessment of the impact of the biotechnological revolution on develop-
ing countries’ food systems began from a discussion on lessons learned from the Green Revo-
lution, the present-day revolutionary force is different in one main respect: the biotechno-
logical revolution in the food systems is being largely driven by private entities whereas the 
Green Revolution was supported by the publicly funded network of research institutes. Many 
policy advisors and institutes recommend that this imbalance between the private and public 
access to biotechnology should be addressed by increased funding towards public research 
institutes, hence assuring independent risk assessment and democratic control over the fruits 
of biotechnological research. Yet, beyond the well-acknowledged need for expensive research 
funding, governments should demonstrate their commitment to food security by strengthening 
and implementing existing environmental legal mechanisms. As stipulated in the previous sec-
tions, the developing countries’ food security can suffer negative consequences not only in 
terms of the potential of environmental risks but also in terms of the risk of allowing the tech-
nological advancements to bypass the needs and interests of developing countries, with poten-
tially disastrous consequences for their economies and ecosystems. Given today’s context of 
globalisation, the protection and enhancement of developing countries’ food security necessi-
tates actions on global forums such as that provided by the FAO’s instruments and by the new 
body of environmental law enshrined in the painstakingly negotiated Cartagena Protocol on 
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Biosafety and the International Treaty on Plant Genetic Resources for Food and Agriculture. 
Furthermore, urgent implementation and more widespread ratification of these instruments, 
which have operationalised the compromise needed in order to minimise the risks and maxi-
mise the benefits of the new technologies, are not only in interest of the developing countries 
but in interest of any developed country government paying lip service to food security and 
environmental concerns. Preservation of biodiversity and farmer’s rights – coupled with re-
search and development directed towards addressing the needs of developing countries – is the 
only strategy through which food security not only of the developing countries but of humani-
ty at large can be improved and assured for the future generations. It is high time to press the 
world’s governments for further ratification and the provision of sufficient financial commit-
ments towards full implementation of these Treaties. 
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